Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles.

Nano-sized particles of ceramic and metallic materials are generated by high-tech industrial activities, and can be generated from worn-out replacement and prosthetic implants. The interaction with the human body of such nanoparticles has been investigated, with a particular emphasis on innate defence mechanisms. Human macrophages (PMA-differentiated myelomonocytic U-937 cells) were exposed in vitro to non-toxic concentrations of TiO(2), SiO(2), ZrO(2), or Co nanoparticles, and their inflammatory response (expression of TLR receptors and co-receptors, and cytokine production) was examined. Expression of TLR receptors was generally unaffected by exposure to the different nanoparticles, except for some notable cases. Exposure to nanoparticles of ZrO(2) (and to a lesser extent TiO(2)), upregulated expression of viral TLR receptors TLR3 and TLR7. Expression of TLR10 was also increased by TiO(2) and ZrO(2) nanoparticles. On the other hand, TLR9 expression was decreased by SiO(2) nano-particles, and expression of the co-receptor CD14 was inhibited by Co nanoparticles. Basal and LPS-induced production of cytokines IL-1beta, TNF-alpha, and IL-1Ra was examined in macrophages exposed to nanoparticles. SiO(2) nanoparticles strongly biased naive macrophages towards inflammation (M1 polarisation), by selectively inducing production of inflammatory cytokines IL-1beta and TNF-alpha. SiO(2) nanoparticles also significantly amplified the inflammatory phenotype of LPS-polarised M1 macrophages. Other ceramic nanoparticles had little influence on cytokine production, either in resting macrophages, or in LPS-activated cells. Generally, Co nanoparticles had an overall pro-inflammatory effect on naive macrophages, by reducing anti-inflammatory IL-1Ra and inducing inflammatory TNF-alpha. However, Co nanoparticles reduced production of IL-1beta and IL-1Ra, but not TNF-alpha, in LPS-polarised M1 macrophages. Thus, exposure to different nanoparticles can modulate, in different ways, the defence/inflammatory capacities of macrophages. A thorough analysis of these biasing effects may shed light on the mechanisms of pathogenesis of several diseases based on dysregulation of the immune response (allergies, autoimmunity, tumours).

[1]  K. Driscoll,et al.  Pulmonary response to inhaled silica or titanium dioxide. , 1991, Toxicology and applied pharmacology.

[2]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[3]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[4]  K. Anderson,et al.  Toll signaling pathways in the innate immune response. , 2000, Current opinion in immunology.

[5]  C. Dinarello,et al.  Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.

[6]  Larry L. Hench,et al.  Biomaterials : an interfacial approach , 1982 .

[7]  G. Valdrè,et al.  Importance of microanalysis in understanding mechanism of transformation in active glassy biomaterials. , 1996, Journal of biomedical materials research.

[8]  S. Goyert,et al.  CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. , 1997, Journal of immunology.

[9]  L. O’Neill The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. , 2000, Biochemical Society transactions.

[10]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.

[11]  W. Arend The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.

[12]  David B Warheit,et al.  TIME COURSE OF QUARTZ AND TiO 2 PARTICLE-INDUCED PULMONARY INFLAMMATION AND NEUTROPHIL APOPTOTIC RESPONSES IN RATS , 2002, Experimental lung research.

[13]  Tomoki Ito,et al.  Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. , 2002, Human immunology.

[14]  S. Swain,et al.  Interleukin 18 , 2001, The Journal of experimental medicine.

[15]  R. Weeratna,et al.  The potential of CpG oligodeoxynucleotides as mucosal adjuvants. , 2001, Critical reviews in immunology.

[16]  N Hussain,et al.  Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. , 2001, Advanced drug delivery reviews.

[17]  B. Beutler,et al.  TLR4 as the mammalian endotoxin sensor. , 2002, Current topics in microbiology and immunology.

[18]  K. Xia,et al.  Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. , 2003, Current gene therapy.

[19]  G. Cooper,et al.  Occupational exposure to crystalline silica and autoimmune disease. , 1999, Environmental health perspectives.

[20]  D. Mosser,et al.  The many faces of macrophage activation , 2003, Journal of leukocyte biology.

[21]  F C Kafatos,et al.  Phylogenetic perspectives in innate immunity. , 1999, Science.

[22]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[23]  L. Babiuk,et al.  Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits. , 2003, Vaccine.

[24]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[25]  A. Florence Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting , 2004, Journal of drug targeting.

[26]  R. Medzhitov,et al.  Toll-like receptors and their ligands. , 2002, Current topics in microbiology and immunology.

[27]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[28]  C. Janeway,et al.  An ancient system of host defense. , 1998, Current opinion in immunology.

[29]  Mitsunobu Sato,et al.  Toll-like receptor signaling in anti-cancer immunity. , 2003, The journal of medical investigation : JMI.